Luxfer (LXFR) executive boosts stake as RSUs vest and shares withheld for taxes
Rhea-AI Filing Summary
Luxfer Holdings executive Jeffrey C. Moorefield reported a series of equity compensation events involving restricted stock units and ordinary shares. On March 17–18, 2026 he exercised a total of 14,191 restricted stock units into ordinary shares and received additional performance-based and time-based RSU grants.
Following these transactions, his direct holdings in Luxfer ordinary shares increased to 18,882 shares. Across the same dates, 5,748 ordinary shares were withheld at prices of about $11.80–$11.82 per share to satisfy tax obligations, which are recorded as dispositions but are not open-market sales.
Positive
- None.
Negative
- None.
Insights
Compensation-related RSU vesting and exercises, with routine tax withholding.
Jeffrey C. Moorefield’s reported activity centers on equity compensation, not open-market trading. He exercised 14,191 restricted stock units into ordinary shares and received new RSU and performance-based RSU awards, which increased his direct equity exposure to 18,882 ordinary shares.
The filing also shows 5,748 ordinary shares withheld at roughly $11.80–$11.82 per share to cover tax liabilities. These F-code dispositions are mechanical and do not represent discretionary sales. With no remaining derivative positions listed, this reflects full vesting and exercise of the reported performance-based RSUs tied to EPS and relative TSR goals.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 921 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 6,763 | $0.00 | -- |
| Exercise | Restricted Stock Units | 6,763 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 5,738 | $0.00 | -- |
| Exercise | Restricted Stock Units | 5,738 | $0.00 | -- |
| Exercise | Ordinary Shares | 921 | $0.00 | -- |
| Tax Withholding | Ordinary Shares | 373 | $11.82 | $4K |
| Exercise | Ordinary Shares | 6,763 | $0.00 | -- |
| Tax Withholding | Ordinary Shares | 2,739 | $11.82 | $32K |
| Exercise | Ordinary Shares | 5,738 | $0.00 | -- |
| Tax Withholding | Ordinary Shares | 2,324 | $11.82 | $27K |
| Exercise | Restricted Stock Units | 769 | $0.00 | -- |
| Exercise | Ordinary Shares | 769 | $0.00 | -- |
| Tax Withholding | Ordinary Shares | 312 | $11.80 | $4K |
Footnotes (1)
- 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. Represents 25% of the Restricted Stock Units granted on March 17, 2025. The remaining Restricted Stock Units will vest in three equal tranches on March 17, 2027, 2028 and 2029. Represents 25% of the Restricted Stock Units granted on March 18, 2024. The remaining Restricted Stock Units will vest in two equal tranches on March 18, 2027 and 2028. Represents the grant of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. Represents the 100% vesting of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. Represents the grant of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. Represents the 100% exercise of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025.
